Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vioser is a private Greek pharmaceutical and medical products company focused on infusion therapy and hospital care products. The company manufactures terminally sterilized infusion and injection solutions, irrigation and urologic solutions, generic antibiotics, and single-use medical devices such as infusion and transfusion sets. Vioser operates GMP-compliant manufacturing in Trikala, Greece and uses Blow/Fill/Seal bottle technology for parenteral solutions. In addition to selling its own products, the company provides contract manufacturing services and distributes selected third-party healthcare products in Greece. Its business is commercial-stage rather than R&D-driven, with activity across Greece and export markets in Europe, Asia, and Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vioser.